Monopar Therapeutics
MNPR
#7537
Rank
HK$3.66 B
Marketcap
HK$540.86
Share price
-1.84%
Change (1 day)
-24.09%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2026 (TTM): -HK$14.95

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$14.97. In 2025 the company made an earnings per share (EPS) of -HK$14.50 an increase over its 2024 EPS that were of -HK$32.22.

EPS history for Monopar Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$14.953.1%
2025-HK$14.50-54.99%
2024-HK$32.2235.2%
2023-HK$23.83-26.75%
2022-HK$32.5313.7%
2021-HK$28.6125.86%
2020-HK$22.7328.89%
2019-HK$17.6445.28%
2018-HK$12.14-80.5%
2017-HK$62.261296.33%
2016-HK$4.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$10.58-29.32%๐Ÿ‡บ๐Ÿ‡ธ USA